Determination of optimal cutoff value to accurately identify glucose-6-phosphate dehydrogenase-deficient heterozygous female neonates

Clin Chim Acta. 2013 Sep 23:424:131-5. doi: 10.1016/j.cca.2013.05.004. Epub 2013 May 13.

Abstract

Background: Conventional screening tests to assess G6PD deficiency use a low cutoff value of 2.10 U/gHb which may not be adequate for detecting females with heterozygous deficiency. The aim of present study was to determine an appropriate cutoff value with increased sensitivity in identifying G6PD-deficient heterozygous females.

Methods: G6PD activity analysis was performed on 51,747 neonates using semi-quantitative fluorescent spot test. Neonates suspected with G6PD deficiency were further analyzed using quantitatively enzymatic assay and for common G6PD mutations. The cutoff values of G6PD activity were estimated using the receiver operating characteristic curve.

Results: Our results demonstrated that using 2.10 U/g Hb as a cutoff, the sensitivity of the assay to detect female neonates with G6PD heterozygous deficiency was 83.3%, as compared with 97.6% using 2.55 U/g Hb as a cutoff. The high cutoff identified 21% (8/38) of the female neonates with partial G6PD deficiency which were not detected with 2.10 U/g Hb. Our study found that high cutoffs, 2.35 and 2.55 U/g Hb, would increase assay's sensitivity to identify male and female G6PD deficiency neonates, respectively.

Conclusions: We established a reliable cutoff value of G6PD activity with increased sensitivity in identifying female newborns with partial G6PD deficiency.

Keywords: ARMS; Cut-off value; Female; G6PD; G6PD deficiency; Heterozygotes; Newborn screening; ROC; amplification refractory mutation system; glucose-6-phosphate-dehydrogenase; receiver operating characteristic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • China / epidemiology
  • Dried Blood Spot Testing
  • Female
  • Glucosephosphate Dehydrogenase / blood*
  • Glucosephosphate Dehydrogenase / genetics
  • Glucosephosphate Dehydrogenase Deficiency / blood
  • Glucosephosphate Dehydrogenase Deficiency / diagnosis*
  • Glucosephosphate Dehydrogenase Deficiency / epidemiology
  • Glucosephosphate Dehydrogenase Deficiency / genetics
  • Heterozygote
  • Humans
  • Infant, Newborn
  • Male
  • Mutation
  • Neonatal Screening*
  • Prevalence
  • ROC Curve

Substances

  • Glucosephosphate Dehydrogenase